PharmaShots | Incisive News in 3 Shots

Subscribe Now

SSc-ILD

Boehringer Ingelheim's Ofev (nintedanib) Receives Health Canada's Approval as the First Therapy to Treat SSc-ILD in Canada

Boehringer Ingelheim's Ofev (nintedanib) Receives Health Canada's Approval as the First Therapy to Treat SSc-ILD in Canada

November 28, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us